Effects of deracoxib and aspirin on serum concentrations of thyroxine, 3,5,3′-triiodothyronine, free thyroxine, and thyroid-stimulating hormone in healthy dogs

American Journal of Veterinary Research

Volumn 67, Issue 4, 2006, Pages 599-603

  Panciera, David L ^a   Refsal, Kent R ^b   Sennello, Kathleen A ^a   Ward, Daniel L ^a  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; DERACOXIB; LIOTHYRONINE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PROTEIN; THYROTROPIN; THYROXINE; UNCLASSIFIED DRUG; SERUM ALBUMIN; SERUM GLOBULIN; SULFONAMIDE;

ALBUMIN BLOOD LEVEL; ANOREXIA; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DOG; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFICACY; FEMALE; HORMONAL REGULATION; HORMONE INHIBITION; LIOTHYRONINE BLOOD LEVEL; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; RANDOMIZATION; THYROID FUNCTION TEST; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; VOMITING; ANIMAL; BLOOD; DRUG EFFECT; METABOLISM; ORAL DRUG ADMINISTRATION; REFERENCE VALUE;

ANIMALIA; CANIS FAMILIARIS;

ADMINISTRATION, ORAL; ANIMALS; ASPIRIN; DOGS; FEMALE; MALE; PLACEBOS; REFERENCE VALUES; SERUM ALBUMIN; SERUM GLOBULINS; SULFONAMIDES; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 33646847507     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.67.4.599     Document Type: Article

References (22)

1. Bishnoi A, Carlson HE, Gruber BE, et al. Effects of commonly prescribed nonsteroidal anti-inflammatory drugs on thyroid hormone measurements. Am J Med 1994;96:235-238.
2. Samuels MH, Pillote K, Asher D, et al. Variable effects of nonsteroidal anti-inflammatory agents on thyroid test results. J Clin Endocrinol Metab 2003;88:5710-5716.
3. Sauve F, Paradis M, Refsal KR, et al. Effects of oral administration of meloxicam, carprofen, and a nutraceutical on thyroid function in dogs with osteoarthritis. Can Vet J 2003;44:474-479.
4. Daminet S, Croubels S, Duchateau L, et al. Influence of acetylsalicylic acid and ketoprofen on canine thyroid function tests. Vet J 2003;166:224-232.
5. Ness TA, Torres SMF, Kramek EA, et al. Effect of dosing and sampling time on serum thyroxine, free thyroxine, and thyrotropin concentrations in dogs following multidose etodolac administration. Vet Ther 2003;4:340-349.
6. Ramirez S, Wolfsheimer KJ, Moore RM, et al. Duration of effects of phenylbutazone on serum total thyroxine and free thyroxine concentrations in horses. J Vet Intern Med 1997;11:371-374.
7. Soijka JE, Hohnson MA, Bottoms GD. Serum triiodothyronine, total thyroxine, and free thyroxine concentrations in horses. Am J Vet Res 1993;54:52-55.
8. Panciera DL, Johnston SA. Results of thyroid function tests and concentrations of plasma proteins in dogs administered etodolac. Am J Vet Res 2002;63:1492-1495.
9. Wang R, Nelson JC, Wilcox RB. Salsalate administration - a potential pharmacological model of the sick euthyroid syndrome. J Clin Endocrinol 1998;83:3095-3099.
10. McConnell RJ. Changes in thyroid function tests during short-term salsalate use. Metabolism 1999;48:501-503.
11. Wang R, Nelson JC, Wilcox RB. Salsalate and salicylate binding to and their displacement of thyroxine from thyroxine-binding globulin, transthyretin, and albumin. Thyroid 1999;9:359-364.
12. Topliss DJ, Kolliniatis E, Barlow JW, et al. Uptake of 3,5,3′-triiodothyronine by cultured rat hepatoma cells is inhibitable by nonbile acid cholephils, diphenylhydantoin, and nonsteroidal anti-inflammatory drugs. Endocrinology 1989;124:980-986.
13. Chopra IJ, Solomon DH, Chua Teco GN, et al. Inhibition of hepatic outer ring monodeiodination of thyroxine and 3,3′,5′-triiodothyronine by sodium salicylate. Endocrinology 1980;106:1728-1734.
14. Foldes O, Langer P, Straussova K, et al. In vivo study of iodothyronine deiodination in rat liver: effect of salicylate on biliary excretion of several iodothyronines. Horm Metab Res 1983;15:147-150.
15. FitzGerald GA, Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med 2001;345:433-442.
16. Panciera DL, MacEwen EG, Atkins CE, et al. Thyroid function tests in euthyroid dogs treated with L-thyroxine. Am J Vet Res 1990;51:22-26.
17. Plumb DC. Veterinary drug handbook. 4th ed. White Bear Lake, Minn: PharmaVet Publishing, 2002;72.
18. Barlow JW, Raggatt LE, Scholz GH, et al. Preferential inhibition of cytoplasmic T3 binding is associated with reduced nuclear binding in cultured cells. Thyroid 1996;6:47-51.
19. Peterson ME, Melian C, Nichols R. Measurement of serum total thyroxine, triiodothyronine, free thyroxine, and thyrotropin concentrations for diagnosis of hypothyroidism in dogs. J Am Vet Med Assoc 1997;211:1396-1402.
20. Kantrowitz LB, Peterson ME, Melian C, et al. Serum total thyroxine, total triiodothyronine, free thyroxine, and thyrotropin concentrations in dogs with nonthyroidal illness. J Am Vet Med Assoc 2001;219:765-769.
21. Vail DM, Panciera DL, Ogilvie GK. Thyroid hormone concentrations in dogs with chronic weight loss, with special reference to cancer cachexia. J Vet Intern Med 1994;8:122-127.
22. Carlson HE, Kaell AT, Schulman PE, et al. Effects of several nonsteroidal anti-inflammatory drugs on thyroid function test. J Rheumatol 1999;26:1856-1857.